Manuel Grossmann

@pmoe 🎯

Venture isn't dead, early stage isn't dead, small funds aren't dead.

Rivia is building the infrastructure layer that changes clinical trial economics, reducing costs by up to 50%. Proud to continue our support in their $15M Series A led by @EarlybirdVC, alongside Defiant, @speedinvest, & @ninacapital.

Super excited to speak about @sensible_bio at @NVIDIAGTC on Tuesday! Ping me if you are around and would like to talk about AI-enabled #mRNA therapeutics design, optimization, and/or manufacturing!

The VC Flight to ‘Deep Tech’ is almost certainly the wrong move for you Mr. Lazy-Narrative VC

Spending some time in Paris next week and hosting a small event with our friends at Singular. DM if you are in town!

Can’t wait for Valinor’s models to be applied to accelerating the diagnosis and treatment of patients with neurological diseases like Alzheimer’s, Parkinson’s, and ALS. We are working with Renew to generate the most robust multimodal datasets available for these conditions.

Looking forward to tonight’s Synapse Munich fireside chat 🔥 Great to connect with the Munich AI x biotech community. Thanks to Nucleate and Amino Collective for the invitation! See you there 🚀 luma.com/ehl0ap32

🧵 We just designed three novel GLP-1 receptor agonists from scratch on a Sunday afternoon using autonomous AI agents on @bio_protocol infrastructure Not a pharma lab. Not a $70M seed round. An AI scientist, a hypothesis on @ScienceBeach, and onchain compute via @Molecule_sci - here's what happened

@DominiqueCAPaul 100%

If you’re not willing to start small, you don’t deserve to do something big. YC is a prime example. It didn’t start as a fund. In 2005, Paul Graham ran a tiny summer programme, basically by himself. 8 teams. $6k each. One weekly dinner. He even cooked the food. Most people never start because they want scale on day one. But big things usually come from loving the small version enough to begin and sticking with it until it grows. But people only see the big thing and say "I want to do that".

This was such much fun!

🤍

Biotech’s latest unicorn Enveda want to use AI to scour thousands of plants for potential medicinal breakthroughs bloomberg.com/news/articles/…

“AC this, wash dryer that, US woohoo, EU boohoo” - Why are we eating this brand-warfare from the outside about us up? Europe has the strongest precision manufacturing in the world, we have leading teams in AI, CV, robotics. Europe is a leader in Automation and Frontier Tech! Not a single NVIDIA chip could be produced without European machines. Not a single American cloud, robotics, or deep-tech firm would operate without European manufacturing or suppliers. But we are too humble. Brainwashed to never celebrate Europe. By outsiders and our local politicians. Time for a change. Europe is the birthplace of industrialization. The home of frontier tech. Time, we act like it. Welcome to the real Europe! 🔥🇪🇺

@lolawajs @maith_d

@robindchnt Time for a walking pad?

go move! how much and how vigorously you move are more important than how old you are as a predictor of the years you’ve got left. outsideonline.com/health/trainin…

I saw it firsthand at the #Lindau2025 Nobel Laureates meeting--international young scientists welcomed and recruited in Germany and elsewhere. Some of the very best are leaving, and many of the best will no longer come. wsj.com/politics/polic…

@DominiqueCAPaul 100% agree with this. See many people jumping around between different industries these days!

The biggest premium in AI atm is picking a problem you care about and sticking with it for a long time.

Exciting job opportunity!🚨 Join our lab at Helmholtz Munich as a Postdoc to develop cutting-edge AI for single cell analysis & drug discovery targeting neuroinflammatory diseases 🧠, collaborating closely with our partners at @UniofOxford! Apply here👇 jobs.helmholtz-muenchen.de/jobposting/7aa…